Biologically, our data suggest that CB2 and TRPV1 may contribute to modulate inflammatory responses in SCD, at least in part through the regulation of macrophage phenotype and iron metabolism-related pathways. This evidence concerns the gene CNR2 and Schnyder corneal dystrophy.